Viracta Therapeutics (VIRX)
(Delayed Data from NSDQ)
$0.74 USD
+0.01 (1.09%)
Updated May 24, 2024 03:40 PM ET
After-Market: $0.74 +0.01 (0.68%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.35 | -0.96% |
Earnings Summary
For their last quarter, Viracta Therapeutics (VIRX) reported earnings of -$0.23 per share, beating the Zacks Consensus Estimate of $-0.35 per share. This reflects a positive earnings surprise of 34.29%. Look out for VIRX's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year decrease of 9.38%.
Earnings History
Price & Consensus
Zacks News for VIRX
Does Sunesis (VIRX) Have the Potential to Rally 335% as Wall Street Analysts Expect?
VIRX: What are Zacks experts saying now?
Zacks Private Portfolio Services